On June 22, Shimadzu Corporation commenced trial sales of its Gut Bacteria Co-Culture Device (hereinafter “the Device”). The Device creates the mimicked environment of the human gut that allows the co-culture*1 of intestinal epithelial cells and gut bacteria. The technologies used in the Device were developed through the joint research with Professor Takane Katayama of the […]
Cambridge, United Kingdom – Congenica, a digital health company that drives Precision Medicine by enabling the rapid analysis and interpretation of genomic data at scale, today announces a strategic partnership with NoorDx, an innovative clinical genomics and research services company located at the KAUST Innovation Cluster in the Kingdom of Saudi Arabia (KSA). The new […]
Exclusive distribution agreement to accelerate product commercialization in key European markets Agreement provides access to CliniSciences’ established distribution channels, customer base, and direct market presence in more than 15 European countries Agreement reaffirms Genomic Vision’s new strategy focused on drug discovery and bioproduction BAGNEUX, France — Genomic Vision (FR0011799907 – GV, – the “Company”), a Euronext-listed biotechnology company […]
MINNEAPOLIS and TOLOCHENAZ, Switzerland — Bio-Techne Corporation (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced it has reached an agreement to acquire Lunaphore, Inc. Bio-Techne anticipates the acquisition to close in the first quarter of its fiscal 2024. Founded in 2014 and headquartered in […]
IRVINE, Calif. — Zymo Research, a leading innovation company for biomedical products and services has donated $25,000 to the Regents of the University of California to support the Center for Virus Research at the University of California, Irvine (UCI). “We are grateful for the generous support from Zymo Research,” said Dr. Thomas Lane, Director Center for Virus Research. “This donation supports us in […]
BRANFORD, Conn. — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointment of Johan Denecke as Senior Vice President of Operations, effective June 20, 2023. Mr. Denecke will be responsible for scaling up production and driving operational and quality excellence in support of the commercialization of Quantum-Si’s next-generation, single-molecule protein sequencing platform. Mr. […]
Vienna – Lexogen, a leading provider of innovative next-generation sequencing solutions, is pleased to announce that it has successfully earnt ISO 13485:2016 certification from Quality Austria. This internationally recognized standard reflects Lexogen’s dedication to designing and delivering the highest quality products for the biotechnology and medical device industry. ISO 13485 is a stringent quality standard intended […]
SOPHiA GENETICS technology to aid research associated with hereditary cancers and disorders BOSTON and LAUSANNE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Ankara Etlik City Hospital, the largest hospital in the capital city of Turkey, is live on the SOPHiA DDM™ […]
Tempus, a leader in artificial intelligence and precision medicine, today introduces its standalone RNA next-generation sequencing assay, Tempus xR. xR is a whole transcriptome panel for solid tumors, reporting clinically relevant fusions for more than 100 targeted genes, as well as altered splicing for MET Exon 14 and EGFRvIII. Tempus has always understood the importance of […]
Selective Suppression Probes- SSP™ SANTA CRUZ, CALIFORNIA, UNITED STATES — RealSeq Biosciences1 has developed a targeted removal probe (Selective Suppression Probe- SSP™) approach to deplete undesired or over-abundant species from RNA samples, resulting in increased reads and greater sequencing depth for small RNAs/miRNAs of interest. Unwanted RNA species can dramatically reduce read depth of the RNAs that researchers […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
